172 related articles for article (PubMed ID: 29693310)
1. Genetic, epigenetic and transcriptional variations at NFATC2IP locus with weight loss in response to diet interventions: The POUNDS Lost Trial.
Sun D; Heianza Y; Li X; Shang X; Smith SR; Bray GA; Sacks FM; Qi L
Diabetes Obes Metab; 2018 Sep; 20(9):2298-2303. PubMed ID: 29693310
[TBL] [Abstract][Full Text] [Related]
2. Macronutrient Intake-Associated FGF21 Genotype Modifies Effects of Weight-Loss Diets on 2-Year Changes of Central Adiposity and Body Composition: The POUNDS Lost Trial.
Heianza Y; Ma W; Huang T; Wang T; Zheng Y; Smith SR; Bray GA; Sacks FM; Qi L
Diabetes Care; 2016 Nov; 39(11):1909-1914. PubMed ID: 27581055
[TBL] [Abstract][Full Text] [Related]
3. DNA Methylation at ABCG1 and Long-term Changes in Adiposity and Fat Distribution in Response to Dietary Interventions: The POUNDS Lost Trial.
Li X; Shao X; Kou M; Wang X; Ma H; Grundberg E; Bazzano LA; Smith SR; Bray GA; Sacks FM; Qi L
Diabetes Care; 2023 Dec; 46(12):2201-2207. PubMed ID: 37770056
[TBL] [Abstract][Full Text] [Related]
4. FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: the POUNDS LOST Trial.
Zhang X; Qi Q; Zhang C; Smith SR; Hu FB; Sacks FM; Bray GA; Qi L
Diabetes; 2012 Nov; 61(11):3005-11. PubMed ID: 22891219
[TBL] [Abstract][Full Text] [Related]
5. TCF7L2 genetic variants modulate the effect of dietary fat intake on changes in body composition during a weight-loss intervention.
Mattei J; Qi Q; Hu FB; Sacks FM; Qi L
Am J Clin Nutr; 2012 Nov; 96(5):1129-36. PubMed ID: 23034957
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y genotype, central obesity, and abdominal fat distribution: the POUNDS LOST trial.
Lin X; Qi Q; Zheng Y; Huang T; Lathrop M; Zelenika D; Bray GA; Sacks FM; Liang L; Qi L
Am J Clin Nutr; 2015 Aug; 102(2):514-9. PubMed ID: 26156739
[TBL] [Abstract][Full Text] [Related]
7. Genetically determined vitamin D levels and change in bone density during a weight-loss diet intervention: the Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) Trial.
Zhou T; Sun D; Heianza Y; Li X; Champagne CM; LeBoff MS; Shang X; Pei X; Bray GA; Sacks FM; Qi L
Am J Clin Nutr; 2018 Nov; 108(5):1129-1134. PubMed ID: 30475961
[TBL] [Abstract][Full Text] [Related]
8. A circadian rhythm-related MTNR1B genetic variant modulates the effect of weight-loss diets on changes in adiposity and body composition: the POUNDS Lost trial.
Goni L; Sun D; Heianza Y; Wang T; Huang T; Martínez JA; Shang X; Bray GA; Smith SR; Sacks FM; Qi L
Eur J Nutr; 2019 Jun; 58(4):1381-1389. PubMed ID: 29516223
[TBL] [Abstract][Full Text] [Related]
9. Impact of polyunsaturated and saturated fat overfeeding on the DNA-methylation pattern in human adipose tissue: a randomized controlled trial.
Perfilyev A; Dahlman I; Gillberg L; Rosqvist F; Iggman D; Volkov P; Nilsson E; Risérus U; Ling C
Am J Clin Nutr; 2017 Apr; 105(4):991-1000. PubMed ID: 28275132
[No Abstract] [Full Text] [Related]
10. Vitamin D metabolism-related genetic variants, dietary protein intake and improvement of insulin resistance in a 2 year weight-loss trial: POUNDS Lost.
Qi Q; Zheng Y; Huang T; Rood J; Bray GA; Sacks FM; Qi L
Diabetologia; 2015 Dec; 58(12):2791-9. PubMed ID: 26416604
[TBL] [Abstract][Full Text] [Related]
11. IRS1 genotype modulates metabolic syndrome reversion in response to 2-year weight-loss diet intervention: the POUNDS LOST trial.
Qi Q; Xu M; Wu H; Liang L; Champagne CM; Bray GA; Sacks FM; Qi L
Diabetes Care; 2013 Nov; 36(11):3442-7. PubMed ID: 24009303
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of intrapericardial and extrapericardial fat tissues during long-term, dietary-induced, moderate weight loss.
Tsaban G; Wolak A; Avni-Hassid H; Gepner Y; Shelef I; Henkin Y; Schwarzfuchs D; Cohen N; Bril N; Rein M; Serfaty D; Kenigsbuch S; Tene L; Zelicha H; Yaskolka-Meir A; Komy O; Bilitzky A; Chassidim Y; Ceglarek U; Stumvoll M; Blüher M; Thiery J; Dicker D; Rudich A; Stampfer MJ; Shai I
Am J Clin Nutr; 2017 Oct; 106(4):984-995. PubMed ID: 28814394
[No Abstract] [Full Text] [Related]
13. Allelic variants of melanocortin 3 receptor gene (MC3R) and weight loss in obesity: a randomised trial of hypo-energetic high- versus low-fat diets.
Santos JL; De la Cruz R; Holst C; Grau K; Naranjo C; Maiz A; Astrup A; Saris WH; MacDonald I; Oppert JM; Hansen T; Pedersen O; Sorensen TI; Martinez JA;
PLoS One; 2011; 6(6):e19934. PubMed ID: 21695122
[TBL] [Abstract][Full Text] [Related]
14. Weight-loss diets modify glucose-dependent insulinotropic polypeptide receptor rs2287019 genotype effects on changes in body weight, fasting glucose, and insulin resistance: the Preventing Overweight Using Novel Dietary Strategies trial.
Qi Q; Bray GA; Hu FB; Sacks FM; Qi L
Am J Clin Nutr; 2012 Feb; 95(2):506-13. PubMed ID: 22237064
[TBL] [Abstract][Full Text] [Related]
15. Dietary Fat Modifies the Effects of FTO Genotype on Changes in Insulin Sensitivity.
Zheng Y; Huang T; Zhang X; Rood J; Bray GA; Sacks FM; Qi L
J Nutr; 2015 May; 145(5):977-82. PubMed ID: 25761503
[TBL] [Abstract][Full Text] [Related]
16. Insulin receptor substrate 1 gene variation modifies insulin resistance response to weight-loss diets in a 2-year randomized trial: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial.
Qi Q; Bray GA; Smith SR; Hu FB; Sacks FM; Qi L
Circulation; 2011 Aug; 124(5):563-71. PubMed ID: 21747052
[TBL] [Abstract][Full Text] [Related]
17. Toward Precision Weight-Loss Dietary Interventions: Findings from the POUNDS Lost Trial.
Qi L; Heianza Y; Li X; Sacks FM; Bray GA
Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630855
[TBL] [Abstract][Full Text] [Related]
18. APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial.
Zhang X; Qi Q; Bray GA; Hu FB; Sacks FM; Qi L
Am J Clin Nutr; 2012 Oct; 96(4):917-22. PubMed ID: 22914552
[TBL] [Abstract][Full Text] [Related]
19. Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin Secretion: The DIETFITS Randomized Clinical Trial.
Gardner CD; Trepanowski JF; Del Gobbo LC; Hauser ME; Rigdon J; Ioannidis JPA; Desai M; King AC
JAMA; 2018 Feb; 319(7):667-679. PubMed ID: 29466592
[TBL] [Abstract][Full Text] [Related]
20. SH2B1 CpG-SNP is associated with body weight reduction in obese subjects following a dietary restriction program.
Mansego ML; Milagro FI; Zulet MA; Martinez JA
Ann Nutr Metab; 2015; 66(1):1-9. PubMed ID: 25471250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
